Home/Keltic Pharma Therapeutics/Professor Andrew Tobin

PA

Professor Andrew Tobin

Co-Founder, GPCR Biology Expert

Keltic Pharma Therapeutics

Therapeutic Areas

Inflammatory Diseases Infectious Diseases Neurology Psychiatry

Keltic Pharma Therapeutics Pipeline

Drug	Indication	Phase
Severe Asthma (FFA4 receptor)	Severe Asthma	Pre-clinical
Malaria	Malaria	Pre-clinical
Neurodegeneration	Alzheimer's Disease	Pre-clinical
Schizophrenia	Schizophrenia	Pre-clinical

Leadership Team at Keltic Pharma Therapeutics

Professor Graeme Milligan

Co-Founder, Molecular Pharmacology Expert

Professor Andrew Jameson

Co-Founder, Chemical Biology Expert, Architect of PEPSMOL©

View full Keltic Pharma Therapeutics profile